At Estel, we just don't sell. We care.

Shop

KOMBIGLYZE XR 5/1000MG 30’S

1,056.45

Add to wishlist Add to compareAsk about product
SKU: A-1534 Category:

Description

Kombiglyze XR 5/1000mg is a combination medication used to manage type 2 diabetes mellitus.

Primary Medical Uses:
– It helps to control high blood sugar levels in adult patients with type 2 diabetes.

Drug Class or Type:
– It is a fixed-dose oral antidiabetic combination.
– Contains two active ingredients: Saxagliptin (a DPP-4 inhibitor) and Metformin (a biguanide).

General Mechanism of Action:
– Saxagliptin works by inhibiting the enzyme DPP-4, which increases the levels of incretin hormones. These hormones help the body produce more insulin when blood sugar is high and reduce glucose production by the liver.
– Metformin decreases glucose production in the liver and improves insulin sensitivity to enhance glucose uptake by muscles and tissues.

Common Forms:
– Extended-release oral tablets taken once daily.

Dosage Instructions:
– The usual dose contains 5 mg of Saxagliptin and 1000 mg of Metformin.
– Taken orally, once daily with meals to reduce gastrointestinal side effects.
– Dosage may be adjusted by the healthcare provider based on the patient’s response and tolerance.

Side Effects, Contraindications, or Interactions:
– Common side effects include gastrointestinal symptoms such as nausea, diarrhea, and abdominal discomfort.
– Other possible side effects are headache, upper respiratory tract infections, and hypoglycemia, especially when combined with other antidiabetic drugs.
– Contraindicated in patients with severe kidney or liver disease, metabolic acidosis, or hypersensitivity to either component.
– Should be used cautiously with medications that affect kidney function or increase lactic acidosis risk.

Regular monitoring of blood sugar and kidney function is advised during treatment.

Reviews

There are no reviews yet.

Be the first to review “KOMBIGLYZE XR 5/1000MG 30’S”

Your email address will not be published. Required fields are marked *